Eli Lilly raises outlook on bumper sales of diabetes and weight loss drugs
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly raised its revenue forecast for 2024, sending its shares soaring, as the world’s biggest drugmaker by market value…







